Northern Trust Corp Orgenesis Inc. Transaction History

Northern Trust Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.39 - $0.63 $62 - $101	-161 Reduced 0.4%	40,512 $24,000
Q1 2024 May 14, 2024	BUY	$0.28 - $0.9 $434 - $1,395	1,551 Added 3.96%	40,673 $33,000
Q4 2023 Feb 13, 2024	SELL	$0.44 - $0.96 $926 - $2,020	-2,105 Reduced 5.11%	39,122 $19,000
Q1 2023 May 15, 2023	BUY	$1.18 - $2.59 $5,900 - $12,950	5,000 Added 13.8%	41,227 $48,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.74 $4,327 - $8,990	-2,404 Reduced 6.22%	36,227 $88,000
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $4,682 - $5,537	-1,018 Reduced 2.57%	38,631 $191,000
Q2 2021 Aug 13, 2021	SELL	$4.19 - $5.88 $633,393 - $888,867	-151,168 Reduced 79.22%	39,649 $201,000
Q1 2021 May 12, 2021	SELL	$4.77 - $8.08 $44,990 - $76,210	-9,432 Reduced 4.71%	190,817 $1.09 Million
Q4 2020 Feb 11, 2021	BUY	$4.4 - $5.63 $5,799 - $7,420	1,318 Added 0.66%	200,249 $901,000
Q3 2020 Nov 16, 2020	SELL	$4.75 - $5.99 $20,149 - $25,409	-4,242 Reduced 2.09%	198,931 $1 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.84 $672,328 - $1.46 Million	186,758 Added 1137.73%	203,173 $1.24 Million
Q4 2019 Feb 14, 2020	BUY	$2.6 - $4.66 $6,084 - $10,904	2,340 Added 16.63%	16,415 $76,000
Q3 2019 Nov 13, 2019	SELL	$4.18 - $4.85 $4,598 - $5,335	-1,100 Reduced 7.25%	14,075 $63,000
Q1 2019 May 13, 2019	BUY	$4.28 - $5.6 $543 - $711	127 Added 0.84%	15,175 $81,000
Q4 2018 Feb 12, 2019	BUY	$3.88 - $7.46 $58,386 - $112,258	15,048 New	15,048 $70,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.